Amsurg Corp. (AMSG) Coverage Initiated at Citigroup Inc.
Stock analysts at Citigroup Inc. began coverage on shares of Amsurg Corp. (NASDAQ:AMSG) in a note issued to investors on Monday. The brokerage set a “buy” rating and a $79.00 price target on the stock. Citigroup Inc.’s price target would suggest a potential upside of 20.78% from the stock’s previous close.
Other equities analysts have also recently issued reports about the company. Jefferies Group reissued a “buy” rating on shares of Amsurg Corp. in a research note on Sunday, July 3rd. Robert W. Baird reissued a “buy” rating on shares of Amsurg Corp. in a research note on Thursday, June 16th. Zacks Investment Research raised Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 target price on the stock in a research note on Monday, July 11th. Goldman Sachs Group Inc. reissued a “buy” rating on shares of Amsurg Corp. in a research note on Friday, June 17th. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $95.00 target price on shares of Amsurg Corp. in a research note on Thursday, July 14th. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Amsurg Corp. presently has a consensus rating of “Buy” and a consensus target price of $92.55.
Shares of Amsurg Corp. (NASDAQ:AMSG) opened at 65.41 on Monday. Amsurg Corp. has a 52-week low of $58.37 and a 52-week high of $87.29. The company has a 50-day moving average price of $65.47 and a 200-day moving average price of $73.60. The stock has a market capitalization of $3.52 billion, a price-to-earnings ratio of 19.41 and a beta of 0.65.
Amsurg Corp. (NASDAQ:AMSG) last announced its quarterly earnings results on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.02. The business had revenue of $758.50 million for the quarter, compared to analysts’ expectations of $769.88 million. Amsurg Corp. had a return on equity of 8.20% and a net margin of 6.53%. The business’s quarterly revenue was up 21.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.97 EPS. On average, equities analysts anticipate that Amsurg Corp. will post $4.33 earnings per share for the current year.
In other Amsurg Corp. news, insider Robert Jon Coward sold 7,500 shares of the business’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $63.65, for a total value of $477,375.00. Following the sale, the insider now directly owns 97,507 shares of the company’s stock, valued at $6,206,320.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.30% of the stock is owned by company insiders.
A number of large investors have recently added to or reduced their stakes in the company. Norges Bank bought a new stake in Amsurg Corp. during the fourth quarter valued at approximately $51,788,000. Capital Growth Management LP bought a new stake in Amsurg Corp. during the second quarter valued at approximately $42,647,000. JPMorgan Chase & Co. increased its stake in Amsurg Corp. by 213.0% in the first quarter. JPMorgan Chase & Co. now owns 802,101 shares of the company’s stock valued at $59,836,000 after buying an additional 545,833 shares during the period. Bank of Montreal Can bought a new stake in Amsurg Corp. during the second quarter valued at approximately $36,148,000. Finally, Goldman Sachs Group Inc. increased its stake in Amsurg Corp. by 33.5% in the first quarter. Goldman Sachs Group Inc. now owns 1,028,828 shares of the company’s stock valued at $76,751,000 after buying an additional 257,891 shares during the period. 98.42% of the stock is currently owned by institutional investors and hedge funds.
Amsurg Corp. Company Profile
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Receive News & Stock Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related stocks with our FREE daily email newsletter.